Fortunato Scotto di Uccio

  • Citations Per Year
Learn More
OBJECTIVES To assess the feasibility and the clinical results following a prespecified bioresorbable vascular scaffold (Absorb BVS) implantation strategy in ST-elevation myocardial infarction (STEMI) patients. BACKGROUNDS Concerns raised about the BVS safety in STEMI setting because a not negligible thrombosis rate was reported within 30 days and 12(More)
Bioresorbable vascular scaffolds (BRS) represent the latest innovation in the field of interventional cardiology. BRS have recently been introduced in routine clinical practice and their use has progressively extended in everyday clinical practice. The BRS use appears theoretically attractive in patients presenting with acute coronary syndromes (ACS) as(More)
  • 1